Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 49 for “"SULFONYLUREAS"”.

  1. Investigating the effect of low-dose sulfonylureas on glucagon secretion in diabetes mellitus

    … which further exacerbates hyperglycaemia. Sulfonylureas used at low concentrations have been shown to partially restore appropriate glucose-regulated glucagon secretion in isolated islets from donors with type 2 diabetes (T2DM). The main objective of this thesis was to investigate whether …

    oxford Repository record for Investigating the effect of low-dose sulfonylureas on glucagon secretion in diabetes mellitus (opens in a new tab)

  2. Effect of berberine on in vitro metabolism of sulfonylureas: a herb-drug interactions study

    … which can lead to toxicity or loss of efficacy. Sulfonylureas are insulin secretagogues and prescribed to treat type 2 diabetes. Berberine is an active component of medicinal herbs and used by individuals to self-regulate the blood glucose levels. Around 8.5 million patients of type 2 diabetes …

    middlesex

  3. A novel approach to support evidence-based medicine: should sulfonylureas remain an acceptable therapy for diabetes?

    … not sufficient, clinicians disagree on whether sulfonylureas should remain a suitable therapy after metformin. While this would be improved with further research investigating the comparative safety of therapeutic options, there is also need for better ways to synthesize available information to …

    bu Repository record for A novel approach to support evidence-based medicine: should sulfonylureas remain an acceptable therapy for diabetes? (opens in a new tab)

  4. Comparative effectiveness of oral antihyperglycemic agents in patients with diabetes and chronic kidney disease

    We sought to compare the safety of sulfonylureas to other oral antihyperglycemic agents (OHAs) in patients with type 2 diabetes (T2DM) and examine whether chronic kidney disease (CKD) is an effect modifier. Using Manitoba Center for Health Policy data, we identified adults with an incident OHA …

    manitoba Repository record for Comparative effectiveness of oral antihyperglycemic agents in patients with diabetes and chronic kidney disease (opens in a new tab)

  5. Soil mobility, octanol-water coefficients, and degradation of six sulfonylurea herbicides

    … 7.0, and 6.51 to 147 at pH 5.5. The pyrimidine sulfonylureas had higher K$\sb{\rm ow}$ values than the triazine sulfonylureas. Mobility determined by soil thin layer chromatography ranged from immobile (R$\sb{\rm f}$ = 0.0) to highly mobile (R$\sb{\rm f}$ = 0.88) depending on herbicide, soil pH, …

    nebraska Repository record for Soil mobility, octanol-water coefficients, and degradation of six sulfonylurea herbicides (opens in a new tab)

  6. Failure of monotherapy in patients with type 2 diabetes: The Korean National Diabetes Program

    … at a 1:1 ratio (metformin vs. sulfonylureas) and 4:1 ratios (metformin vs. meglitinides and metformin vs. alpha-glucosidase inhibitors [aGIs]). The hazard ratios of treatments (compared with metformin) were determined via Cox’s proportional hazards regression modeling. RESULTS: …

    ajou Repository record for Failure of monotherapy in patients with type 2 diabetes: The Korean National Diabetes Program (opens in a new tab) Embargoed until 9999-12-31

  7. Chromatographic studies of drug -protein binding in diabetes

    … and the number of binding sites on HSA for sulfonylureas. The first part of this study examined the binding of two sulfonylureas to non-glycated HSA. Frontal analysis and competition studies indicated that the sulfonylureas had two major classes of binding sites on HSA, with strong …

    nebraska Repository record for Chromatographic studies of drug -protein binding in diabetes (opens in a new tab)

  8. Use of Glucose-Lowering Medication in Patients with Chronic Kidney Diseases and Type 2 Diabetes

    … lower odds of starting SGLT2i or GLP-1RA than sulfonylureas. Patients with cardiovascular disease or hyperlipidemia were more likely to start SGLT2i or GLP-1RA. Aim 3 showed that use of newer glucose-lowering medications (SGLT2i or GLP-1RA) when compared with sulfonylureas use was associated …

    umn Repository record for Use of Glucose-Lowering Medication in Patients with Chronic Kidney Diseases and Type 2 Diabetes (opens in a new tab)

  9. THE EFFECT OF TOLBUTAMIDE ON INSULIN-COMPLEXES IN VIVO

    … involved. That the acute effect of the sulfonylureas, particularly that of tolbutamide, might be due to direct stimulation of pancreatic beta cells was first suggested by Loubatieres (79). This theory received additional support from the work of Creutzfeldt and Soeling (35), Yalow and …

    nebraska Repository record for THE EFFECT OF TOLBUTAMIDE ON INSULIN-COMPLEXES IN VIVO (opens in a new tab)

  10. Advanced Separation Methods for the Analysis of Drugs and Other Targets by High-Performance Liquid Chromatography

    … elution to characterize the interactions between sulfonylureas and normal or AGE-modified HSA. Competition studies were also conducted to examine binding by first-generation sulfonylureas to the two major drug binding sites of normal and modified HSA. The affinity of the drugs was found to vary …

    nebraska Repository record for Advanced Separation Methods for the Analysis of Drugs and Other Targets by High-Performance Liquid Chromatography (opens in a new tab)

  11. Potential Overtreatment of Older Adults with Diabetes and Dementia: A Matched Cohort Study Using Real-World Data

    … From 2017–2018 to 2023–2024, the use of insulin, sulfonylureas, and metformin/ dipeptidyl peptidase-4 inhibitors [DPP4i] declined in older adults, regardless of dementia status. In 2023-2024, 17.2% and 6.0% of older patients with type 2 diabetes and dementia were on insulin and sulfonylureas, …

    jhu Repository record for Potential Overtreatment of Older Adults with Diabetes and Dementia: A Matched Cohort Study Using Real-World Data (opens in a new tab) Embargoed until 2027-05-01

  12. Persistence and mobility of triasulfuron, metsulfuronmethyl, and chlorsulfuron in alkaline soils / Ajit K. Sarmah.

    … it was unlikely to be a major loss pathway for sulfonylureas in alkaline soils. The herbicides were found to have low sorption, very little retardation and high mobility, moving at a marginally slower rate than water. Degradation did not follow first-order kinetics, but rather a two-stage …

    adelaide Repository record for Persistence and mobility of triasulfuron, metsulfuronmethyl, and chlorsulfuron in alkaline soils / Ajit K. Sarmah. (opens in a new tab)

  13. Genistein-Induced Potentiation Effect on Glucose-Stimulated Insulin Secretion (GSIS) in INS-1 β-cells

    … target for prevention of overt type 2 diabetes. Sulfonylureas have been used to stimulate insulin secretion in patients with type 2 diabetes. However, glucose-dependent insulinotropic molecules are required to improve diabetic hyperglycemia since sulfonylureas have glucose-independent …

    ajou Repository record for Genistein-Induced Potentiation Effect on Glucose-Stimulated Insulin Secretion (GSIS) in INS-1 β-cells (opens in a new tab) Embargoed until 9999-12-31

  14. Purification of Recombinant HIS6-GFP-Preptin Fusion Protiens

    … it as a unique alternative to traditional sulfonylureas and osteogenic agents. In this study, we developed a purification protocol for green fluorescent-preptin fusion proteins. These fusion proteins will be used to investigate the functional significance of residues Pro17, Val18, Gly19, …

    columbus-state Repository record for Purification of Recombinant HIS6-GFP-Preptin Fusion Protiens (opens in a new tab)

  15. Pathogenesis and pharmacological treatment options for patients suffering with type 2 diabetes mellitus

    … anti-diabetic medications such a Biguanides and sulfonylureas, or insulin therapy can be used. Research continues to focus on the development of new therapeutic strategies to better manage type 2 diabetes.

    bu Repository record for Pathogenesis and pharmacological treatment options for patients suffering with type 2 diabetes mellitus (opens in a new tab)

  16. Intermittent fasting and its potential role in treating type 2 diabetes

    … the market to treat T2DM, including biguanides, sulfonylureas, glinides, glucagon-like peptide-1 agonists, sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors. Through various mechanisms, these drugs help lower blood glucose levels. Intermittent fasting has been an …

    bu Repository record for Intermittent fasting and its potential role in treating type 2 diabetes (opens in a new tab)

  17. Cardiovascular safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus

    … 0.41, 0.79) with DPP-4i was lower compared to sulfonylureas. In the longitudinal analysis of high-risk individuals, DPP-4i was associated with lower risk for MACE than sulfonylurea (aHR=0.84; 95% CI: [0.7, 0.9]), and with no increased risk for MACE compared to metformin (aHR=1.07; 95% CI: [1.0, …

    jhu Repository record for Cardiovascular safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus (opens in a new tab)

  18. Hypertension and diabetes treatments and risk of adverse outcomes among breast cancer patients

    … diuretics) and diabetes treatments (metformin, sulfonylureas, insulin therapy and other diabetes treatments) after their breast cancer diagnosis. Primary outcomes were any second breast cancer events (SBCEs, recurrence or second primary breast cancer, n=791), recurrence per se (n=627), and …

    washington Repository record for Hypertension and diabetes treatments and risk of adverse outcomes among breast cancer patients (opens in a new tab)

  19. The role of glucose metabolism in the etiology of Alzheimer’s disease and its implications in treatment

    … such as Metformin, thiazolidinediones, sulfonylureas, incretins, and intranasal insulin have shown some potential as future treatment options for Alzheimer’s Disease but require further investigation. Some non-pharmacological approaches, such as the ketogenic diet, have also been …

    bu Repository record for The role of glucose metabolism in the etiology of Alzheimer’s disease and its implications in treatment (opens in a new tab)

Page 1 of 3